Malcisbo - the sweet vaccines company

Malcisbo develops novel carbohydrate-based vaccines for human & animal health. Based on a novel platform technology, we develop vaccines against bacterial and parasitic diseases.

Our development projects are:

  • Campylobacter vaccine, for use in broiler chickens, to prevent human food poisoning
  • Actinobacillus pleuropneumoniae vaccine, for use in pigs, to prevent economic loss during food production
  • Haemonchus vaccine, for use in small ruminants, to prevent economic loss during food production
  • Heartworm and Hookworm vaccines, for use in dogs and in humans

Latest News

  • 01 November 2012

    Ranked #4 in the Top100 in Switzerland
    Malcisbo was again ranked in the Top10 of the Top100 Swiss Start-up companies.

     

  • 09 October 2012

    On Tuesday, 9th of October 2012, Malcisbo was granted the precious CTI Start-up Label form the Commission for Technology and Innovation CTI.
    This Label certifies that Malcisbo has successfully completed the CTI Start-up Coaching program and is now ready for Venture financing.

  • 19 October 2011

    Excellent ranking on place 9 as best vaccine startup in the Top 100 Swiss startup survey.